FindTrial
Sign In

The influence of CECR2 on proliferation of Laryngeal carcinoma and the possible mechanism.

The influence of CECR2 on proliferation of Laryngeal carcinoma and the possible mechanism.

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040554
Enrollment
Unknown
Registered
2020-12-02
Start date
2020-12-10
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal carcinoma

Interventions

Case series:No

Sponsors

Shanghai Jiao Tong University Af?liated Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with laryngeal cancer and underwent surgical treatment in Shanghai Sixth People's Hospital; 2. Aged 18 to 80 years old; 3. Participate in this clinical study voluntarily, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient had received radiotherapy, chemotherapy, targeted therapy and so on before the operation; 2. The researcher considered that there was any reason not to participate in the study.

Design outcomes

Primary

MeasureTime frame
CECR2;—

Countries

China

Contacts

Public ContactYi Hongliang

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

18817615702@163.com+86 18817615702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026